DELFI Diagnostics
Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. The company was founded in 2019 and is based in Baltimore, Maryland.
AI Machine LearningBiotechnologyCancer ScreeningClinical ResearchClinical TrialsLaboratory-Developed TestsLiquid Biopsy TestsMonitoring Researchdelfidiagnostics.com
DELFI Diagnostics
Delfi Diagnostics detects cancer early, when it is most curable, using high-precision non-invasive blood tests. It uses artificial intelligence and genome sequencing to detect unique patterns of DNA fragmentation in the blood of patients. The company was founded in 2019 and is based in Baltimore, Maryland.
AI Machine LearningBiotechnologyCancer ScreeningClinical ResearchClinical TrialsLaboratory-Developed TestsLiquid Biopsy TestsMonitoring Researchdelfidiagnostics.com
HQBaltimore, US
Team Size176
Open Jobs13
Total Funding$331M
Latest Fundraise4 years ago
